Mutation in the β2m gene is not a frequent event in head and neck squamous cell carcinomas

Human Immunology

Volumn 60, Issue 8, 1999, Pages 697-706

  Feenstra, Manita ^a   Rozemuller, Erik ^a   Duran, Karen ^a   Stuy, Ilonka ^a   Van Den Tweel, Jan ^a   Slootweg, Pieter ^a   De Weger, Roel ^a   Tilanus, Marcel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

2m; Expression; HLA class I; SBMA; TAP l; Tumors

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; GENE MUTATION; HEAD AND NECK CARCINOMA; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; DOWN-REGULATION; EXONS; HEAD AND NECK NEOPLASMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0032813848     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00015-4     Document Type: Article

References (32)

1. Townsend A., Bodmer H. Antigen recognition by class I restricted T lymphocytes. Ann Rev Immunol. 7:1989;601.
2. Barber L.D., Parham P. Peptide binding to major histocompatability complex molecules. Annu Rev Cell Biol. 9:1993;163.
3. Sadasivan B., Lehner P.J., Ortmann B., Spies T., Cresswell P. Roles for calreticulin and a novel Glycoprotein, tapasin, in the interaction of MHC Class I molecules with TAP. Immunity. 5:1996;103.
4. Ortmann B, Androlewicz M, Cresswell P: MHC Class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368, 864, 1994.
5. Neefjes J.J., Hammerling H.J., Momburg F. Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmatic reticilum of intact cells precedes the binding of peptide. J Exp Med. 178:1993;1971.
6. Maffei A., Papadopoulos K., Harris P.E. MHC Class I antigen processing pathways. Human Immunology. 54:1997;91.
7. Garrido F., Cabrera T., Lopez-Nevot M.A., Ruiz-Cabello F. HLA Class I antigens in human tumors. Adv Cancer Res. 67:1995;155.
8. Ferrone S., Marincola F.M. Loss of HLA Class I antigens by melanoma cells molecular mechanisms, functional significance and clinical relevance . Immunol Today. 16:1995;487.
9. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P.L. Natural history of HLA expression during tumour development. Immunol Today. 14:1993;491.
10. Garrido F., Ruiz-Cabello F., Cabrera T., Perez-Villar J.J., Lopez-Botet M., Duggan-Keen M., Stern P. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today. 18:1997;89.
11. Keating P.J., Cromme F.V., Duggan-Keen M., Snijders P.J.F., Walboomers J.M.M., Hunter R.D., Dyer P.A., Stern P.L. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br J Cancer. 72:1995;405.
12. Shanmugaratnam K, Sobin LH: Histological typing of tumours of the upper respiratory tract and ear. 2nd Edition, Springer-Verlag: 1991.
13. Stam N.J., Vroom ThM, Peters P.J., Pastoors E.B., Ploegh H.L. HLA-A and HLA-B- specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno- electronmicroscopy. Int Immunol. 2:1990;113.
14. Kleijmeer M.J., Kelly A., Geuze H.J., Slot J.W., Townsend A., Trowsdale J. Location of MHC-encoded transporters in the endoplasmatic reticulum and cis-Golgi. Nature. 357:1992;342.
15. van Endert P.M., Tampé R., Meyer T.H., Tisch R., Bach J.-F., McDevitt H.O. A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity. 1:1994;1.
16. Rozemuller E.H., Eliaou J.F., Baxter-Lowe L.A., Charron D., Kronick M., Tilanus M.G.J. An evaluation of a multi-center study on HLA-DPB1 typing using solid phase Taq-cycle sequencing chemistry. Tissue Antigens. 46:1995;96.
17. Rammensee H.-G., Falk K., Rötschke O. Peptides naturally presented by MHC Class I molecules. Annu Rev Immunol. 11:1993;213.
18. Boon T. Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res. 58:1992;177.
19. Wang R.-F., Rosenberg S. Human tumor antigens recognized by T lymphocytes implications for cancer therapy . J leukocyte Biol. 60:1996;296.
20. Mattijssen V, De Mulder HM, Schalkwijk L, Manni JJ, Van 't Hof-Grootenboer B, Ruiter DJ: HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites. Int J Cancer, Supplement 6:95, 1991.
21. Vora A.R., Rodgers S., Parker A.J., Start R., Rees R.C., Murray A.K. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. Br J Cancer. 76:1997;836.
22. Kovats S., Main E.K., Librach C., Stubblebine M., Fischer S.J., Demars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 248:1990;220.
23. D'Urso C., Wang Z., Cao Y., Tatake R., Zeff R.A., Ferrone S. Lack of HLA Class I antigen expression by cultured melanoma cells FO-1 due to a defect in β2- microglobulin gene expression. J Clin Invest. 87:1990;284.
24. Güssow D., Rein R., Ginjaar I., Hochstenbach F., Seemann G., Kottman A., Ploegh H.L. The human β2-microglobulin gene primary structure and defenition of the transcriptional unit. J Immunol. 139:1987;3132.
25. Wang Z., Margulies L., Hicklin D.J., Ferrone S. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I expression. Tissue Antigens. 47:1996;382.
26. Bicknell D.C., Rowan A., Bodmer W.F. β2-microglobulin gene mutations A study of established colorectal cell lines and fresh tumors . Proc Natl Acad Sci USA. 91:1994;4751.
27. Trymbulak W.P., Zeff R.A. Expression of HLA class I molecules assembled with structural variants of human β2-microglobulin. Immunogenetics. 46:1997;418.
28. Seliger B., Maeurer M.J., Ferrone S. Tap off-tumors on. Immmunol Today. 18:1997;292.
29. Kurokohchi K., Carrington M., Mann D.L., Simonis T.B., Alexander-Miller M.A., Feinstone S.M., Akatsuka T., Berzofsky J.A. Expression of HLA Class I molecules and the transporter associated with antigen processing in hepatocelular carcinoma. Hepatology. 23:1996;1181.
30. Scheltinga S.A., Johnston-Dow L.A., White B.A., Gordijn-van der Zwan A.-W., Bakema J.E., Rozemuller E.H., van den Tweel J.G., Kronick M.N., Tilanus M.G.J. A generic sequencing based typing approach for the identity of HLA-A diversity. Tissue Antigens. 57:1997;120.
31. Wei M.L., Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 356:1992;443.
32. Chen H.L., Gabrilovich D., Tampé R., Girgis K.R., Nadaf S., Carbone D.P. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nature Genet. 13:1996;210.